The Pharmaceutical Journal
Vol 278 No 7443 p310
17 March 2007

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

• White Paper (4)
• Funding for services
• Prescription charges
• Community pharmacy (2)
• Pharmacist prescribing
• Chlamydia testing
• Pfizer products
• Medicines recycling
• Skill mix
• Retention fees
• Retail pharmacy

Letters to the Editor

Pfizer products

Would I face sanctions today?

From Mr G. A. Fox, MRPharmS

Some 40-odd years ago I owned a pharmacy that was blighted by a new one way street and parking meters. The financial damage was immediate and the effect on cash flow was enormous. My first action was to alert my two wholesalers, Sangers and UniChem. Within days the Sangers representative called and offered me six months’ credit on the account. I heard nothing from UniChem. A week so later I received a “30 days or else” letter from its solicitors.

From that day I refused to trade with the company ever again, even refusing to stock its products. You may well say mine was an extreme reaction. However, it was my right as an individual and if I were still in practice I would continue that embargo.

I wonder what sanctions I would have faced for not being in a position to supply Pfizer products to NHS patients.

Gerald Fox
Dunstable, Bedfordshire

Send your letter to The Editor

Previous Topic (Chlamydia testing)
Next Topic (Medicines recycling)